Study of Ezatiostat (Telintra Tablets) for Treatment of Severe Chronic Neutropenia

Summary

This is a multicenter Phase 2 randomized parallel-group study to determine the effect of Telintra treatment on severe chronic neutropenia. Patients will be randomized to Telintra or enter an observation period with an option to crossover to Telintra treatment in a 1:1 allocation.

Timeline

Start

2009-04

Primary completion

2013-05

Completion

2013-05

Outcome

Outcome not reported

Stopped (Business): “Study TLK199.2103 was terminated for business reasons.”

Drugs

Indications